Cigna Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +8.8%
EBITDA: -2.4%
EBIT: +4.2%
EPS: +30.5%
Free cash flow: +27.5%
Operating cash flow: +18.4%

Forward estimates

Revenue: +5.3%
EBITDA: +25.3%
EPS: +33.5%

Three-year CAGR

Revenue: +15.1%
EBITDA: +3.6%
EBIT: +2.6%
Net income: -3.9%
EPS: +1.0%
Free cash flow: +4.5%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.